0001209191-22-018891.txt : 20220315 0001209191-22-018891.hdr.sgml : 20220315 20220315173017 ACCESSION NUMBER: 0001209191-22-018891 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220312 FILED AS OF DATE: 20220315 DATE AS OF CHANGE: 20220315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Konidaris Tasos CENTRAL INDEX KEY: 0001320982 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 22742426 MAIL ADDRESS: STREET 1: 103 JFK PARKWAY CITY: SHORT HILLS STATE: NJ ZIP: 07078 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-12 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001320982 Konidaris Tasos C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 0 1 0 0 Executive Vice President & CFO Class A Common Stock 2022-03-12 4 M 0 87719 A 211635 D Restricted Stock Units 2022-03-12 4 M 0 87719 0.00 D Class A Common Stock 87719 175439 D Represents the number of shares of the Issuer's Class A Common Stock awarded to the reporting person in connection with the vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 12, 2020, the reporting person was granted 350,877 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. /s/ Jason Daly, Attorney-in-Fact 2022-03-15